Similarly, the concentrations of IGF-1 in the ischemia group were 178.2 ± 33.5 ng/mL and 188.7 ± 34.5 ng/mL at days 4 and 7, respectively, which were significantly increased following MSC treatment to 233.1 ± 18.9 ng/mL (p < 0.05) and 245.8 ± 25.7 ng/mL, respectively (p < 0.05) (Figures 8(b) and 8(c)). This evidence concerns the gene IGF1 and ischemia.